Target intelligence / Profile preview

Voltage-dependent anion-selective channel 1 (VDAC1)

Target
VDAC1
Molecular classification
Ion channel, Mitochondrial porin, Metabolite transporter, Scaffold protein, Enzyme (NADH:ferricyanide reductase)
01

Overview

Voltage-dependent anion-selective channel 1 (VDAC1) is a 19-strand beta-barrel protein that serves as the primary "gatekeeper" of the outer mitochondrial membrane (OMM) [9, 12, 15]. It functions as a critical conduit for the exchange of ions and metabolites—most notably ATP and ADP—between the mitochondria and the cytoplasm, thereby regulating cellular energy homeostasis and bioenergetics [2, 9, 20]. Beyond its role in metabolism, VDAC1 is central to the intrinsic pathway of apoptosis; under stress or specific signaling, VDAC1 can undergo oligomerization to form large pores that facilitate the release of pro-apoptotic factors like cytochrome c into the cytosol [1, 5, 7]. In many cancers, VDAC1 is significantly overexpressed, where it associates with proteins such as hexokinase and Bcl-2 to promote a high glycolytic rate and provide resistance to cell death [12, 13, 20]. Conversely, in neurodegenerative diseases like Alzheimer's and Parkinson's, pathological VDAC1 oligomerization and calcium dysregulation contribute to premature neuronal loss [15, 18]. Therapeutic strategies involving VDAC1 include small molecules like erastin that induce ferroptotic cell death in tumors, and inhibitors like VBIT-4 that prevent oligomerization to protect cells from neurodegeneration and inflammation [7, 18, 19].

Other names
VDAC-1Porin 1Mitochondrial porin31HL31HMPlasmalemmal porinOuter mitochondrial membrane protein porin 1Sperm binding protein 1a
02

Mechanism of action

Modulation of VDAC1 channel gating, oligomerization, or protein-protein interactions (e.g., with HK-II or Bcl-2) to regulate mitochondrial metabolite exchange and the release of pro-apoptotic factors.

03

Biological functions

Metabolic transport (ATP/ADP and ions)Apoptosis regulationCalcium homeostasisCell volume regulationMitophagyScaffolding for metabolic enzymes (e.g., Hexokinase)Transmembrane electron transport
04

Disease associations

Cancer (e.g., lung, breast, cervical, and gastric cancer)Neurodegenerative disease (Alzheimer's, Parkinson's, ALS, Huntington's disease)Type 2 diabetesInflammatory disease (Lupus, Colitis)Cardiovascular disease (Myocardial infarction)Glaucoma
05

Safety considerations

Potential for systemic toxicity due to ubiquitous expression in most cell typesRisk of disrupting essential cellular bioenergetics (ATP/ADP flux)Narrow therapeutic window when balancing pro-apoptotic (cancer) vs anti-apoptotic (neurodegeneration) effectsBlood-brain barrier (BBB) penetration challenges for CNS indicationsIsoform selectivity (avoiding unintentional modulation of VDAC2 or VDAC3)
06

Interacting drugs

Erastin

8 more in the full profile.

07

Biomarkers

VDAC1 protein expression levelsVDAC1-ΔC (hypoxia-induced C-terminal truncated isoform)VDAC1 oligomerization stateMitochondrial membrane potential (Δψm)

Beyond the preview

Go deeper on Voltage-dependent anion-selective channel 1 (VDAC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent anion-selective channel 1 (VDAC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call